Gender-specific influences on incidence, screening, treatment, and outcome of colorectal cancer;Geschlechtsspezifische Einflüsse auf Inzidenz, Screening, Behandlung und Ergebnis des kolorektalen Karzinoms

Zentralblatt fur Chirurgie - Zeitschrift fur Allgemeine, Viszeral- und Gefasschirurgie

Volumn 138, Issue 4, 2013, Pages 434-441

  Grundmann, R T ^a   Meyer, F ^b  

^a Universitätsklinikum Magdeburg A Ö R ^*  (Germany)

^b UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

colorectal cancer; gender; incidence; screening; survival

Indexed keywords

ADULT; AGED; ARTICLE; COLORECTAL TUMOR; CROSS-SECTIONAL STUDY; DELAYED DIAGNOSIS; ESTROGEN THERAPY; FEMALE; GERMANY; HUMAN; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; MORTALITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SURVIVAL RATE;

ADULT; AGED; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; DELAYED DIAGNOSIS; ESTROGEN REPLACEMENT THERAPY; FEMALE; GERMANY; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ADJUSTMENT; RISK FACTORS; SEX FACTORS; SURVIVAL RATE;

EID: 84883100294     PISSN: 0044409X     EISSN: 14389592     Source Type: Journal    
DOI: 10.1055/s-0033-1350631     Document Type: Article

References (73)

1. Grundmann R. T., Meyer F. Geschlechtsspezifische Einflüsse auf die Ergebnisse der Gefäßchirurgie. Zentralbl Chir: 2013; 138 210 218
2. Murphy G., Devesa S. S., Cross A. J. et al. Sex disparities in colorectal cancer incidence by anatomic subsite, race and age. Int J Cancer: 2011; 128 1668 1675
3. Beiträge zur Gesundheitsberichterstattung des Bundes Krebs in Deutschland 2007/2008. Berlin Robert Koch-Institut: 2012
4. Ferlay J., Autier P., Boniol M. et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol: 2007; 18 581 592 (Pubitemid 46359643)
5. Abotchie P. N., Vernon S. W., Du X. L. Gender differences in colorectal cancer incidence in the United States, 1975-2006. J Womens Health (Larchmt): 2012; 21 393 400
6. Nguyen S. P., Bent S., Chen Y. H. et al. Gender as a risk factor for advanced neoplasia and colorectal cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol: 2009; 7 676 681
7. Gao R. N., Neutel C. I., Wai E. Gender differences in colorectal cancer incidence, mortality, hospitalizations and surgical procedures in Canada. J Public Health (Oxf): 2008; 30 194 201
8. Rondagh E. J., Masclee A. A., van der Valk M. E. et al. Nonpolypoid colorectal neoplasms: gender differences in prevalence and malignant potential. Scand J Gastroenterol: 2012; 47 80 88
9. Brändstedt J., Wangefjord S., Nodin B. et al. Gender, anthropometric factors and risk of colorectal cancer with particular reference to tumour location and TNM stage: a cohort study. Biol Sex Differ: 2012; 3 23
10. Dai Z., Xu Y. C., Niu L. Obesity and colorectal cancer risk: a meta-analysis of cohort studies. World J Gastroenterol: 2007; 13 4199 4206 (Pubitemid 47377159)
11. Rapp K., Schroeder J., Klenk J. et al. Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer: 2005; 93 1062 1067 (Pubitemid 41548403)
12. Ning Y., Wang L., Giovannucci E. L. A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies. Obes Rev: 2010; 11 19 30
13. Laake I., Thune I., Selmer R. et al. A prospective study of body mass index, weight change, and risk of cancer in the proximal and distal colon. Cancer Epidemiol Biomarkers Prev: 2010; 19 1511 1522
14. Campbell P. T., Jacobs E. T., Ulrich C. M. et al. Colon Cancer Family Registry. Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst: 2010; 102 391 400
15. Deng L., Gui Z., Zhao L. et al. Diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis. Dig Dis Sci: 2012; 57 1576 1585
16. Krämer H. U., Schöttker B., Raum E. et al. Type 2 diabetes mellitus and colorectal cancer: meta-analysis on sex-specific differences. Eur J Cancer: 2012; 48 1269 1282
17. Krämer H. U., Müller H., Stegmaier C. et al. Type 2 diabetes mellitus and gender-specific risk for colorectal neoplasia. Eur J Epidemiol: 2012; 27 341 347
18. Campbell P. T., Deka A., Jacobs E. J. et al. Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men. Gastroenterology: 2010; 139 1138 1146
19. Chlebowski R. T., Wactawski-Wende J., Ritenbaugh C. et al. Womens Health Initiative Investigators. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med: 2004; 350 991 1004 (Pubitemid 38269276)
20. Hannaford P. C., Selvaraj S., Elliott A. M. et al. Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioners oral contraception study. BMJ: 2007; 335 651
21. Hendifar A., Yang D., Lenz F. et al. Gender disparities in metastatic colorectal cancer survival. Clin Cancer Res: 2009; 15 6391 6397
22. Koo J. H., Jalaludin B., Wong S. K. et al. Improved survival in young women with colorectal cancer. Am J Gastroenterol: 2008; 103 1488 1495 (Pubitemid 351813902)
23. Rudolph A., Toth C., Hoffmeister M. et al. Colorectal cancer risk associated with hormone use varies by expression of estrogen receptor beta. Cancer Res: 2013; 73 3306 3315
24. Nüssler N. C., Reinbacher K., Shanny N. et al. Sex-specific differences in the expression levels of estrogen receptor subtypes in colorectal cancer. Gend Med: 2008; 5 209 217
25. Knüpfer H., Preiss R. Serum interleukin-6 levels in colorectal cancer patients-a summary of published results. Int J Colorectal Dis: 2010; 25 135 140
26. Sharma A., Greenman J., Walker L. G. et al. Differences in cytokine levels due to gender in colorectal cancer patients. Cytokine: 2010; 50 91 93
27. Schmiegel W., Pox C., Reinacher-Schick A. et al. S3-Leitlinie [Kolorektales Karzinom" Z Gastroenterol: 2008; 46 1 73
28. Schoppmeyer K., Spieker H., Mössner J. Vorsorgemuffel oder Screeningversager? Vorsorgeverhalten von Patienten mit kolorektalem Karzinom in der Region Leipzig. Dtsch Arztebl Int: 2009; 106 195 201
29. Ruthotto F., Papendorf F., Wegener G. et al. Participation in screening colonoscopy in first-degree relatives from patients with colorectal cancer. Ann Oncol: 2007; 18 1518 1522 (Pubitemid 47365485)
30. Chao A., Connell C. J., Cokkinides V. et al. Underuse of screening sigmoidoscopy and colonoscopy in a large cohort of US adults. Am J Public Health: 2004; 94 1775 1781 (Pubitemid 39331769)
31. Ko C. W., Kreuter W., Baldwin L. M. Persistent demographic differences in colorectal cancer screening utilization despite Medicare reimbursement. BMC Gastroenterol: 2005; 5 10
32. Sinicrope P. S., Goode E. L., Limburg P. J. et al. A population-based study of prevalence and adherence trends in average risk colorectal cancer screening, 1997 to 2008. Cancer Epidemiol Biomarkers Prev: 2012; 21 347 350
33. Sieverding M., Matterne U., Ciccarello L. Gender differences in FOBT use: evidence from a large German survey. Z Gastroenterol: 2008; 46 01 S47 S51 (Pubitemid 351548169)
34. Griffin J. M., Burgess D., Vernon S. W. et al. Are gender differences in colorectal cancer screening rates due to differences in self-reporting? Prev Med: 2009; 49 436 441
35. Wardle J., Miles A., Atkin W. Gender differences in utilization of colorectal cancer screening. J Med Screen: 2005; 12 20 27 (Pubitemid 40445072)
36. von Wagner C., Baio G., Raine R. et al. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol: 2011; 40 712 718
37. Regula J., Rupinski M., Kraszewska E. et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med: 2006; 355 1863 1872 (Pubitemid 44664644)
38. Brenner H., Hoffmeister M., Arndt V. et al. Gender differences in colorectal cancer: implications for age at initiation of screening. Br J Cancer: 2007; 96 828 831 (Pubitemid 46376632)
39. Gancayco J., Soulos P. R., Khiani V. et al. Age-based and sex-based disparities in screening colonoscopy use among Medicare beneficiaries. J Clin Gastroenterol: 2013; Apr 29. [Epub ahead of print]
40. Lin O. S., Kozarek R. A., Schembre D. B. et al. Screening colonoscopy in very elderly patients: prevalence of neoplasia and estimated impact on life expectancy. JAMA: 2006; 295 2357 2365 (Pubitemid 43788103)
41. U.S. Preventive Services Task Force Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med: 2008; 149 627 637
42. Gross C. P., Soulos P. R., Ross J. S. et al. Assessing the impact of screening colonoscopy on mortality in the medicare population. J Gen Intern Med: 2011; 26 1441 1449
43. Richards M. A., Westcombe A. M., Love S. B. et al. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet: 1999; 353 1119 1126 (Pubitemid 29155203)
44. Esteva M., Leiva A., Ramos M. et al. DECCIRE GROUP. Factors related with symptom duration until diagnosis and treatment of symptomatic colorectal cancer. BMC Cancer: 2013; 13 87
45. Pedersen A. F., Olesen F., Hansen R. P. et al. Social support, gender and patient delay. Br J Cancer: 2011; 104 1249 1255
46. Ogiso S., Yamaguchi T., Hata H. et al. Evaluation of factors affecting the difficulty of laparoscopic anterior resection for rectal cancer: "narrow pelviso" is not a contraindication. Surg Endosc: 2011; 25 1907 1912
47. Paquette I. M., Kemp J. A., Finlayson S. R. Patient and hospital factors associated with use of sphincter-sparing surgery for rectal cancer. Dis Colon Rectum: 2010; 53 115 120
48. Morris E, Quirke P, Thomas JD et al. Unacceptable variation in abdominoperineal excision rates for rectal cancer: time to intervene? Gut: 2008; 57 1690 1697
49. Kang C. Y., Halabi W. J., Chaudhry O. O. et al. Risk factors for anastomotic leakage after anterior resection for rectal cancer. JAMA Surg: 2013; 148 65 71
50. Masoomi H., Buchberg B., Dang P. et al. Outcomes of right vs. left colectomy for colon cancer. J Gastrointest Surg: 2011; 15 2023 2028
51. Cone M. M., Herzig D. O., Diggs B. S. et al. Dramatic decreases in mortality from laparoscopic colon resections based on data from the Nationwide Inpatient Sample. Arch Surg: 2011; 146 594 599
52. van Leeuwen B. L., Påhlman L., Gunnarsson U. et al. The effect of age and gender on outcome after treatment for colon carcinoma. A population-based study in the Uppsala and Stockholm region. Crit Rev Oncol Hematol: 2008; 67 229 236
53. Martling A., Granath F., Cedermark B. et al. Gender differences in the treatment of rectal cancer: a population based study. Eur J Surg Oncol: 2009; 35 427 433
54. Vlug M. S., Bartels S. A., Wind J. et al. Collaborative LAFA Study Group. Which fast track elements predict early recovery after colon cancer surgery? Colorectal Dis: 2012; 14 1001 1008
55. Masoomi H., Kang C. Y., Chaudhry O. et al. Predictive factors of early bowel obstruction in colon and rectal surgery: data from the Nationwide Inpatient Sample, 2006-2008. J Am Coll Surg: 2012; 214 831 837
56. Paulson E. C., Wirtalla C., Armstrong K. et al. Gender influences treatment and survival in colorectal cancer surgery. Dis Colon Rectum: 2009; 52 1982 1991
57. Storli K. E., Sondenaa K., Bukholm I. R. et al. Overall survival after resection for colon cancer in a national cohort study was adversely affected by TNM stage, lymph node ratio, gender, and old age. Int J Colorectal Dis: 2011; 26 1299 1307
58. Purim O., Gordon N., Brenner B. Cancer of the colon and rectum: potential effects of sex-age interactions on incidence and outcome. Med Sci Monit: 2013; 19 203 209
59. Weissenberger C., Geissler M., Otto F. et al. Anemia and long-term outcome in adjuvant and neoadjuvant radiochemotherapy of stage II and III rectal adenocarcinoma: the Freiburg experience (1989-2002). World J Gastroenterol: 2006; 12 1849 1858
60. Sjo O. H., Berg M., Merok M. A. et al. Peritoneal carcinomatosis of colon cancer origin: highest incidence in women and in patients with right-sided tumors. J Surg Oncol: 2011; 104 792 797
61. Derwinger K., Gustavsson B. A study of aspects on gender and prognosis in synchronous colorectal cancer. Clin Med Insights Oncol: 2011; 5 259 264
62. Meguid R. A., Slidell M. B., Wolfgang C. L. et al. Is there a difference in survival between right- versus left-sided colon cancers? Ann Surg Oncol: 2008; 15 2388 2394
63. Benedix F., Kube R., Meyer F. et al. Colon/Rectum Carcinomas (Primary Tumor) Study Group. Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum: 2010; 53 57 64
64. Benedix F., Meyer F., Kube R. et al. Karzinome des rechten und linken Kolons - verschiedene Tumorentitäten? Zentralbl Chir: 2010; 135 312 317
65. Weiss J. M., Pfau P. R., OConnor E. S. et al. Mortality by stage for right- versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results-Medicare data. J Clin Oncol: 2011; 29 4401 4409
66. Giesinger J., Kemmler G., Mueller V. et al. Are gender-associated differences in quality of life in colorectal cancer patients disease-specific? Qual Life Res: 2009; 18 547 555
67. Zutshi M., Hull T., Shedda S. et al. Gender differences in mortality, quality of life and function after restorative procedures for rectal cancer. Colorectal Dis: 2013; 15 66 73
68. Schmidt C. E., Bestmann B., Küchler T. et al. Gender differences in quality of life of patients with rectal cancer. A five-year prospective study. World J Surg: 2005; 29 1630 1641 (Pubitemid 41779866)
69. Krouse R. S., Herrinton L. J., Grant M. et al. Health-related quality of life among long-term rectal cancer survivors with an ostomy: manifestations by sex. J Clin Oncol: 2009; 27 4664 4670
70. Sloan J. A., Goldberg R. M., Sargent D. J. et al. Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer. J Clin Oncol: 2002; 20 1491 1498 (Pubitemid 34260527)
71. Chansky K., Benedetti J., Macdonald J. S. Differences in toxicity between men and women treated with 5-fluorouracil therapy for colorectal carcinoma. Cancer: 2005; 103 1165 1171 (Pubitemid 40328086)
72. Gamelin E., Delva R., Jacob J. et al. Individual fluorouracil dose adjustment based on pharmacokinetic follow-up compared with conventional dosage: results of a multicenter randomized trial of patients with metastatic colorectal cancer. J Clin Oncol: 2008; 26 2099 2105
73. Shugarman L. R., Bird C. E., Schuster C. R. et al. Age and gender differences in Medicare expenditures at the end of life for colorectal cancer decedents. J Womens Health (Larchmt): 2007; 16 214 227 (Pubitemid 46536931)